Related Experiment Video

Updated: Mar 14, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

SIK2 Restricts Autophagic Flux To Support Triple-Negative Breast Cancer Survival

Kimberly E Maxfield1,2, Jennifer Macion2, Hariprasad Vankayalapati3

  • 1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Molecular and Cellular Biology
|October 5, 2016
PubMed

Insights

Triple-negative breast cancer (TNBC) cells rely on salt inducible kinase 2 (SIK2) to survive. Inhibiting SIK2 triggers cell death in specific TNBC subtypes by reactivating a tumor suppressor mechanism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Triple-negative breast cancer (TNBC) is molecularly heterogeneous, yet treatment options remain limited to non-specific cytotoxic therapies.
  • Understanding TNBC subtypes is crucial for developing targeted interventions.

Purpose of the Study:

  • To identify novel therapeutic targets for TNBC by screening for molecular vulnerabilities.
  • To investigate the role of salt inducible kinase 2 (SIK2) in TNBC survival and progression.

Main Methods:

  • Large-scale loss-of-function screening to identify essential genes in TNBC.
  • Genetic and pharmacological inhibition of SIK2 in cell lines and in vivo models.
  • Analysis of autophagic flux and cell viability following SIK2 inhibition.
  • Assessment of ATG5's role in SIK2 inhibition-induced cell death.

Main Results:

  • Salt inducible kinase 2 (SIK2) was identified as essential for TNBC cell survival.
  • SIK2 inhibition increased autophagic flux, leading to selective cell death in TNBC, particularly the claudin-low subtype.
  • Depletion of ATG5 rescued cell viability, confirming the role of autophagy in SIK2 inhibition-induced death.
  • SIK2 is critical for TNBC tumor growth in vivo.

Conclusions:

  • Claudin-low TNBC cells depend on SIK2 to suppress excessive autophagic activation.
  • SIK2 inhibition represents a potential therapeutic strategy to re-engage tumor suppressor mechanisms in TNBC.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K
Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes11:01

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Published on: August 24, 2021

3.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K